Literature DB >> 28282062

Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study.

C Wilde1, A Poostchi1, R L Mehta2, H K MacNab3, J G Hillman3, S A Vernon4, W M Amoaku1.   

Abstract

ImportanceThere is paucity of data on prevalence and disease asymmetry of age-related macular degeneration (AMD), particularly the earlier stages, in the UK population.Objective and PurposeTo determine the prevalence of age-related macular degeneration in an elderly Caucasian UK population.DesignCross-sectional population study, 2002-2006.ParticipantsResidents in the study area of Bridlington aged 65 years and older.MethodsFull-ophthalmic examination was undertaken in 3549 participants, of eligible 6319 Caucasian population (response rate of 56%). Non-stereoscopic Colour fundus photographs (30°) were graded masked using a modified Rotterdam Classification for 3475 (98%) participants with gradable images. Prevalence for different AMD grades were calculated. Demographic details were analysed then integrated with the AMD gradings for full analysis. Prevalence rates for the different AMD Grades were calculated, as well as the age-specific prevalences.ResultsAMD prevalence in the worst eye were 38.5% grade 0, 41.4% grade 1, 12.8% grade 2, 2.8% grade 3, and 4.6% grade 4. Geographic atrophy (grade 4a) occurred in 2.5%, and neovascular AMD (grade 4b) in 1.8%. Prevalence increased with age such that grade 4 (advanced) AMD was 2.2% in the 65-69 years group, 15.8% for the 85-90, and 21.2% for over 90 years. There was significant asymmetry between the two eyes of individuals with advanced AMD (P<0.001), such that vision loss was unilateral. Persons with more advanced AMD grades were more likely to be dissatisfied with their vision.ConclusionsAdvanced AMD occurs more commonly in the UK Caucasian population than previously reported. Significant asymmetry between the two eyes occurs in individuals with unilateral advanced AMD so that visual impairment statistics do not represent true prevalence of advanced AMD. Persons with more advanced AMD were more likely to be dissatisfied with their vision.

Entities:  

Mesh:

Year:  2017        PMID: 28282062      PMCID: PMC5519272          DOI: 10.1038/eye.2017.30

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  43 in total

1.  Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q.

Authors:  M L Klein; D W Schultz; A Edwards; T C Matise; K Rust; C B Berselli; K Trzupek; R G Weleber; J Ott; M K Wirtz; T S Acott
Journal:  Arch Ophthalmol       Date:  1998-08

2.  The grading and prevalence of macular degeneration in Chesapeake Bay watermen.

Authors:  N M Bressler; S B Bressler; S K West; S L Fine; H R Taylor
Journal:  Arch Ophthalmol       Date:  1989-06

3.  Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study.

Authors:  Christina A Korb; Ulrike B Kottler; Christian Wolfram; René Hoehn; Andreas Schulz; Isabella Zwiener; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

4.  Prevalence of age-related maculopathy at two points in time in an elderly British population.

Authors:  A J Dickinson; J M Sparrow; A M Duke; J R Thompson; J M Gibson; A R Rosenthal
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

Authors:  C C Klaver; J J Assink; R van Leeuwen; R C Wolfs; J R Vingerling; T Stijnen; A Hofman; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

6.  The prevalence of age-related maculopathy: the visual impairment project.

Authors:  M R VanNewkirk; M B Nanjan; J J Wang; P Mitchell; H R Taylor; C A McCarty
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

Review 7.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

Review 8.  Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis.

Authors:  Alicja R Rudnicka; Zakariya Jarrar; Richard Wormald; Derek G Cook; Astrid Fletcher; Christopher G Owen
Journal:  Ophthalmology       Date:  2011-12-15       Impact factor: 12.079

9.  Prevalence of early and late age-related macular degeneration in India: the INDEYE study.

Authors:  Tiruvengada Krishnan; Ravilla D Ravindran; Gudlavalleti V S Murthy; Praveen Vashist; Kathryn E Fitzpatrick; R Duraisami Thulasiraj; Neena John; Giovanni Maraini; Monica Camparini; Usha Chakravarthy; Astrid E Fletcher
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-20       Impact factor: 4.799

10.  Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland. The Greenland Inuit Eye Study.

Authors:  Mads Varis Nis Andersen; Thomas Rosenberg; Morten la Cour; Jens F Kiilgaard; Jan U Prause; Poul Helge Alsbirk; Knut Borch-Johnsen; Tunde Peto; Bendix Carstensen; Alan C Bird
Journal:  Ophthalmology       Date:  2008-02-11       Impact factor: 12.079

View more
  17 in total

1.  Prevalence of peripapillary choroidal neovascular membranes (PPCNV) in an elderly UK population-the Bridlington eye assessment project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajnikant L Mehta; Jonathan G Hillman; Hamish K MacNab; Marco Messina; Gaspare Monaco; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

2.  Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.

Authors:  Aaron Y Lee; Thomas Butt; Emily Chew; Elvira Agron; Traci E Clemons; Catherine A Egan; Cecilia S Lee; Adnan Tufail
Journal:  Br J Ophthalmol       Date:  2017-08-23       Impact factor: 4.638

3.  Prevalence of reticular pseudodrusen in an elderly UK Caucasian population-The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajnikant L Mehta; Jonathan G Hillman; Hamish K MacNab; Marco Messina; Marco Morales; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2018-03-01       Impact factor: 3.775

4.  Mesenchymal stem cells-derived exosomes ameliorate blue light stimulation in retinal pigment epithelium cells and retinal laser injury by VEGF-dependent mechanism.

Authors:  Guang-Hui He; Wei Zhang; Ying-Xue Ma; Jing Yang; Li Chen; Jian Song; Song Chen
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

Review 5.  The Diagnosis and Treatment of Age-Related Macular Degeneration.

Authors:  Andreas Stahl
Journal:  Dtsch Arztebl Int       Date:  2020-07-20       Impact factor: 5.594

6.  Prevalence of optic disc haemorrhages in an elderly UK Caucasian population and possible association with reticular pseudodrusen-the Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Rajesh Narendran; Hamish K MacNab; Jonathan G Hillman; Phillip Alexander; Winfried M Amoaku; Stephen A Vernon
Journal:  Eye (Lond)       Date:  2018-11-01       Impact factor: 3.775

7.  Characteristics of Geographic atrophy in an elderly UK population-The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002-2006).

Authors:  Craig Wilde; Ali Poostchi; Jonathan G Hillman; Hamish K MacNab; Stephen A Vernon; Winfried M Amoaku
Journal:  Eye (Lond)       Date:  2020-08-31       Impact factor: 4.456

8.  Cone photoreceptors in human stem cell-derived retinal organoids demonstrate intrinsic light responses that mimic those of primate fovea.

Authors:  Aindrila Saha; Elizabeth Capowski; Maria A Fernandez Zepeda; Emma C Nelson; David M Gamm; Raunak Sinha
Journal:  Cell Stem Cell       Date:  2022-01-31       Impact factor: 25.269

9.  Variations in Treatment Delivery for Patients with Neovascular AMD in the UK: Results from an Ophthalmology Trainee Clinical Research Network Study.

Authors:  Daren Hanumunthadu; Victoria A Nowak; Farida Hassan; Ibtesham Hossain; Darshak S Patel; Lamia Hamidovic; Dalia Abdulhussein; Isra Hausien; Esther Papamichael; Meena Arunakirinathan; Claudia Quijano; Sheena George; Praveen J Patel
Journal:  Ophthalmol Ther       Date:  2017-08-28

10.  Subretinal Saline Protects the Neuroretina From Thermic Damage During Laser Induction of Experimental Choroidal Neovascularization in Pigs.

Authors:  Silja Hansen; Anne Louise Askou; Morten la Cour; Thomas J Corydon; Toke Bek
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.